Cargando…
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
The utility of wild-type outer membrane vesicle (wtOMV) vaccines against serogroup B (MenB) meningococcal disease has been explored since the 1970s. Public health interventions in Cuba, Norway and New Zealand have demonstrated that these protein-based vaccines can prevent MenB disease. Data from lar...
Autores principales: | Holst, Johan, Oster, Philipp, Arnold, Richard, Tatley, Michael V., Næss, Lisbeth M., Aaberge, Ingeborg S., Galloway, Yvonne, McNicholas, Anne, O’Hallahan, Jane, Rosenqvist, Einar, Black, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901813/ https://www.ncbi.nlm.nih.gov/pubmed/23857274 http://dx.doi.org/10.4161/hv.24129 |
Ejemplares similares
-
Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda
por: Guerin, Philippe J., et al.
Publicado: (2008) -
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine
por: Marjuki, Henju, et al.
Publicado: (2019) -
Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012) -
Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008) -
Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents
por: Petousis-Harris, Helen, et al.
Publicado: (2015)